In the quartile of patients transplanted with the highest CD34+ graft content (>8.25 × 10^6 /kg) increased incidence of grade III-IV acute GVHD (18% vs. 7%, P = .02) was observed (Figure 3). The gene discussed is CD34; the disease is acute graft versus host disease.